Status:

COMPLETED

Cognitive Behavioral Couple Therapy for Perinatal Distress

Lead Sponsor:

Sameera Shafiq

Conditions:

Perinatal Depression

Perinatal Anxiety

Eligibility:

All Genders

19-45 years

Phase:

NA

Brief Summary

The hypotheses of the study are * There will be differences in perceived perinatal distress, dyadic coping strategies, social support, domains of quality of life, and well-being in couples at Pre- an...

Detailed Description

The research questions of the study are • How effective will psychopharmacological treatment, CBCT (with or without Zikr) and combined medicine-CBCT (with or without Zikr) interventions be in reducin...

Eligibility Criteria

Inclusion

  • The fourth month of pregnancy till the seventh month of the antenatal period.
  • One week after delivery/birth till one year of a child in the postnatal period.
  • Screened by PPDS as high-risk couples (for the level of severe symptomology) for Major Depressive Disorder (cut-off score 29 to 42) and/or Generalized Anxiety Disorder (cut-off score 17 to 24), and their Comorbidity.
  • Dose requirements in any one of the antidepressant and/or anxiolytic, such as escitalopram (5-10 mg), sertraline (12.5-25 mg), and/or alprazolam (0.25-0.50 mg) per day.
  • Wives accompanied by their husbands.
  • Willingness to participate as a couple in the study.
  • No physical disorder is present and/or no medication use.
  • No psychiatric disorder history or presence
  • No psychotropic medication use (presence or history)
  • No disability is present.

Exclusion

  • Unwilling couples to participate in the study.
  • Wife and/or couple is in an emergency.
  • Wife and/or couple has unstable mental health.
  • Wife accompanied by close relatives other than a spouse.
  • Wife in the first week of delivery.
  • Dose requirements in any one of the antidepressant and/or anxiolytic, such as escitalopram (above10 mg), sertraline (above 25 mg), and/or alprazolam (above 0.50 mg) per day.
  • Couples screened with depressive disorder and/or anxiety disorder having psychotic features.
  • Couples screened with depressive disorder and/or anxiety disorder having suicidal ideation.
  • Couples screened with depressive disorder and/or anxiety disorder having mania/hypomanic features.
  • Couples having diabetes.
  • Couples having cardiovascular disorders.
  • Presence or history of any physical or psychiatric disorder and/or use of medications
  • Any intellectual, visual, or hearing disability present in either spouse of a couple.

Key Trial Info

Start Date :

August 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 28 2023

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT06001021

Start Date

August 15 2023

End Date

October 28 2023

Last Update

August 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Gujrat

Gujrat, Pakistan